check_circleStudy Completed

Magnetic Resonance Imaging, Liver Neoplasms

Bayer Identifier:

90444

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate the diagnostic efficacy of contrast-enhanced MRI with a single intravenous injection of Gd-EOB-DTPA versus contrast-enhanced spiral CT in patients with known or suspected focal malignant liver lesions

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
178
Trial Dates
August 2001 - January 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A multicenter intra-individual comparative study to evaluate the diagnostic efficacy of contrast-enhanced MRI with a single intravenous injection of Gd-EOB-DTPA (SH L 569 B) at a dose of 25 μmol/kg BW versus contrast-enhanced spiral CT in patients with known or suspected focal malignant liver lesions
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.